Clinical trial

Effects of Radiotherapy in Borderline and Malignant Phyllodes Tumors After R0 Resection

NCT06780059

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

RADIATION · Unmapped registry intervention Adjuvant Radiotherapy Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention R0 resection Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Effects of Radiotherapy in Borderline and Malignant Phyllodes Tumors After R0 Resection

Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2024-12-30

PhaseN/A

Conditions

Radiotherapy, Adjuvantunresolved

Phyllodes Breast Tumorverified · MONDO: breast phyllodes tumor

Prognosisunresolved

Interventions

Adjuvant RadiotherapyRADIATION

R0 resectionPROCEDURE

Sponsors & collaborators

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen Universitylead sponsor

Mapped research locations

GuangzhouGuangdong, China2 NanchangJiangxi, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06780059 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.